Analysis of speech and language alterations in diabetics affected by COVID-19

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.31006

Keywords:

COVID-19; Diabetes; Speech therapy; Swallowing disorders; Somnolence.

Abstract

Purpose: To compare the speech therapy changes in diabetic and non-diabetic users, hospitalized with COVID 19. Methods: This is a case-control, observational and retrospective study carried out through the analysis of medical records of users infected with COVID-19 hospitalized at General Hospital of Goiânia, with and without a diagnosis of diabetes, in the biennium 2020-2021. Results: A total of 100 individuals infected with COVID-19 participated in the study. In this sample, the prevalence of individuals without diabetes was observed. This sample consists mostly of male individuals and the mean age observed was 54.4 ± 13.7 years. In this study, sleepiness was a prevalent condition in diabetic patients. This finding may be the result of several factors, in particular, the metabolic changes associated with viral infection. Conclusion: There were no significant speech-language disorders in diabetic patients with COVID-19. However, we observed that the prevalence of alterations in the alertness level was higher in this group, and that they can impact the decision-making in speech-language pathology conducts.

References

World Health Organization declares novel coronavirus (2019a-nCoV) sixth public health emergency of international concern. (2020). Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2020.25.5.200131e.

Singh, V., & Mishra, V. (2020). Coronavirus disease 2019 (COVID-19): Current situation and therapeutic options. Coronaviruses, 01. https://doi.org/10.2174/2666796701999201005211854

Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging, 12(7). https://doi.org/10.18632/aging.103000

Ricci, G, (2017). Queixa de deglutição em pacientes com diabetes melito tipo I e tipo II. Tese de mestrado [Internet]. Ribeirão Preto, SP, 2017 https://teses.usp.br/teses/disponiveis/17/17151/tde-1204-2018-115816/publico.

Gross, J. L., Silveiro, S. P., Camargo, J. L., Reichelt, A. J., & Azevedo, M. J. de. (2002). Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arquivos Brasileiros de Endocrinologia & Metabologia, 46(1), 16–26. https://doi.org/10.1590/S0004-27302002000100004

Sociedade Brasileira de Diabetes [Internet]. SBD, 2019. https://www.diabetes.org.br/publico/diabetes-tipo-1/66-tudo-sobre-diabetes/581.

Silva, A. D., Júnior, N. M., Damasceno, D. D., Guimarães, N. S., & Gomes, J. M. G. (2020). Estado nutricional, fatores de risco e comorbidades em adultos portadores de diabetes mellitus tipo 2. HU Revista, 46, 1–9. https://doi.org/10.34019/1982-8047.2020.v46.28790.

Ayres, J. S. (2020). A metabolic handbook for the COVID-19 pandemic. Nature Metabolism, 2(7), 572–585. https://doi.org/10.1038/s42255-020-0237-2 CHAN J, et. al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. Journal of Clinical Microbiology. 2020. doi/10.1128/JCM.00310-20.

Perilli, G., Saraceni, C., Daniels, M. N., & Ahmad, A. (2012). Diabetic Ketoacidosis: A Review and Update. Current Emergency and Hospital Medicine Reports, 1(1), 10–17. https://doi.org/10.1007/s40138-012-0001-3.

Neto D., Pires A. (2010). Crises hiperglicêmicas agudas no diabetes mellitus. Aspectos atuais. Rev Bras Clin Med [Internet] 2010. [acesso: 22 jan. 2022]. 2010;8(3):246-53. http://files.bvs.br/upload/S/1679-1010/2010/v8n3/a011.pdf.

Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R. E., & Acton, S. (2000). A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9. Circulation Research, 87(5). https://doi.org/10.1161/01.res.87.5.e1

Pinto G. (2022). Avaliação da aplicabilidade de um programa com a rede bayesiana na probabilidade de pnrumonia aspirativa em pacientes com acidente vascular cerebral isquêmico agudo. Tese de mestrado [Internet]. Curitiba-2013. https://acervodigital.ufpr.br/bitstream/handle/1884/34802/R%20-%20D%20-%20GISELE%20SANTANA%20PINTO.pdf?sequence=1&isAllowed=y.

Rofes, L., Arreola, V., Mukherjee, R., & Clavé, P. (2014). Sensitivity and specificity of the Eating Assessment Tool and the Volume‐Viscosity Swallow Test for clinical evaluation of oropharyngeal dysphagia. Neurogastroenterology & Motility, 26(9), 1256–1265. https://doi.org/10.1111/nmo.12382

Conselho Nacional de Saúde (Brasil). (2012). Resolução Nº 466, de 12 de dezembro de 2012. Dispõe sobre as normas aplicáveis a pesquisas com seres humanos. Diário Oficial da União [Internet] 12 de dezembro de 2012. https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html

Ventura I, (2021). Gugging Swallowing Screen na avaliação clínica da deglutição. Escola Superior de Saúde da Universidade do Algarve. Tese de mestrado [Internet]. 2018.

https://repositorio.ipl.pt/bitstream/10400.21/8587/4/GUGGING%20SWALLOWING %20SCREEN %20na %20avalia%C3%A7 %C3%A3o%20cl%C3%ADnica%20da%20degluti%C3%A7%C3%A3o.pdf.

Padovani A. (2010). Protocolo fonoaudiológico de introdução e introdução da alimentação por via oral para pacientes com risco de disfagia (PITA). Teses USP [Internet] 2010. https://www.teses.usp.br/teses/disponiveis/5/5162/tde19042010-110604/publico/PadovaniARP2010.pdf.

Carmo, L. F. dos S., Santos, F. A. A. dos, Mendonça, S. C. B. de, Araújo, B. C. L., Carmo, L. F. dos S., Santos, F. A. A. dos, Mendonça, S. C. B. de, & Araújo, B. C. L. (2018). Gerenciamento do risco de broncoaspiração em pacientes com disfagia orofaríngea. Revista CEFAC, 20(4), 532–540. https://doi.org/10.1590/1982-021620182045818

Mahase, E. (2020). Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds. BMJ, m2422. https://doi.org/10.1136/bmj.m2422

Ferreira L., Adricopulo A. Medicamentos e tratamentos para a Covid-19. [Internet] Sep-Dec 2020. https://www.scielo.br/j/ea/a/gnxzKMshkcpd7kgRQy3W7bP/abstract/?lang=pt

Published

06/08/2022

How to Cite

SANTOS, K. K. N. dos .; ARRUDA, Y. de C. M.; RODRIGUES, D. L. da M. . Analysis of speech and language alterations in diabetics affected by COVID-19. Research, Society and Development, [S. l.], v. 11, n. 10, p. e09111031006, 2022. DOI: 10.33448/rsd-v11i10.31006. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/31006. Acesso em: 20 apr. 2024.

Issue

Section

Health Sciences